We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$39.9B
1-Year Est. Return
29.7%
This Fund
S&P 500
This Quarter
Est. Return
+6.62%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$11.1B
AUM Growth
+$989M
(+9.8%)
Cap. Flow
+$432M
Cap. Flow
% of AUM
3.9%
Top 10 Holdings %
Top 10 Hldgs %
14.96%
Holding
1,372
New
66
Increased
556
Reduced
543
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$45.7M |
| 2 |
Morgan Stanley
MS
|
+$44.1M |
| 3 |
Eli Lilly
LLY
|
+$32.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$30.1M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$29.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$51.6M |
| 2 |
Oracle
ORCL
|
+$40M |
| 3 |
Equity Residential
EQR
|
+$34.6M |
| 4 |
Citigroup
C
|
+$31.3M |
| 5 |
ExxonMobil
XOM
|
+$26.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.49% |
| 2 | Technology | 14.87% |
| 3 | Financials | 14.25% |
| 4 | Consumer Discretionary | 10.2% |
| 5 | Industrials | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
T. Rowe Price
TROW
$23.9B
| $1.64M | 0.01% |
24,080
+1,298
| +6% | +$92K |
|
|
TIF
702
DELISTED
Tiffany & Co.
TIF
| $1.64M | 0.01% |
17,204
-1,667
| -9% | -$142K |
|
|
DMC
703
Del Monte Corp
DMC
$1.41B
| $1.64M | 0.01% |
27,646
-19,503
| -41% | -$1.15M |
|
704
Gartner
IT
$10.1B
| $1.64M | 0.01% |
15,146
+1,487
| +11% | +$153K |
|
705
Teva Pharmaceuticals
TEVA
$40.8B
| $1.63M | 0.01% |
50,684
+9,360
| +23% | +$319K |
|
706
Huron Consulting
HURN
$2.41B
| $1.62M | 0.01% |
38,576
+25,037
| +185% | +$1.1M |
|
707
Conagra Brands
CAG
$6.94B
| $1.62M | 0.01% |
40,196
+3,325
| +9% | +$133K |
|
708
Fabrinet
FN
$15.6B
| $1.62M | 0.01% |
38,583
| – | – |
|
709
Rayonier Advanced Materials
RYAM
$604M
| $1.62M | 0.01% |
120,358
-8,149
| -6% | -$114K |
|
710
ONE Gas
OGS
$4.87B
| $1.61M | 0.01% |
23,895
| – | – |
|
711
Artesian Resources
ARTNA
$355M
| $1.61M | 0.01% |
49,557
-5,009
| -9% | -$159K |
|
712
Cheniere Energy
LNG
$55.2B
| $1.61M | 0.01% |
33,975
-21,428
| -39% | -$988K |
|
713
Corpay
CPAY
$25B
| $1.6M | 0.01% |
10,599
-7,081
| -40% | -$1.11M |
|
|
HR
714
DELISTED
Healthcare Realty Trust Incorporated
HR
| $1.58M | 0.01% |
48,757
-29,754
| -38% | -$921K |
|
715
Genuine Parts
GPC
$17.1B
| $1.58M | 0.01% |
17,120
-514
| -3% | -$49.4K |
|
|
SYKE
716
DELISTED
SYKES Enterprises Inc
SYKE
| $1.58M | 0.01% |
53,628
+21,773
| +68% | +$621K |
|
717
BorgWarner
BWA
$13.1B
| $1.56M | 0.01% |
42,367
+22,378
| +112% | +$815K |
|
|
STOR
718
DELISTED
STORE Capital Corporation
STOR
| $1.56M | 0.01% |
65,237
-37,810
| -37% | -$917K |
|
719
Central Garden & Pet Co Class A
CENTA
$2.37B
| $1.56M | 0.01% |
+56,009
| New | +$1.45M |
|
720
Genworth Financial
GNW
$3.76B
| $1.55M | 0.01% |
+375,632
| New | +$1.45M |
|
|
GPT
721
DELISTED
Gramercy Property Trust
GPT
| $1.53M | 0.01% |
58,350
-36,420
| -38% | -$978K |
|
722
Ingevity
NGVT
$2.51B
| $1.52M | 0.01% |
24,909
-3,358
| -12% | -$190K |
|
|
SAFE
723
Safehold
SAFE
$1.16B
| $1.51M | 0.01% |
26,324
+12,335
| +88% | +$709K |
|
724
STAG Industrial
STAG
$7.38B
| $1.51M | 0.01% |
60,379
-20,454
| -25% | -$499K |
|
725
Goodyear
GT
$2B
| $1.48M | 0.01% |
41,146
-88,967
| -68% | -$3.02M |
|
Similar funds
HF
KBC Group's Q1 2017 Portfolio in Review
As of Q1 2017, KBC Group held 1,372 positions worth $11.1B, up 9.8% from $10.1B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
KBC Group deployed $432M of net new capital in Q1 2017, opening 66 new positions and adding to 556 existing holdings. Its largest new stake was LogMein, Inc.: 156,863 shares worth $15.3M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $51.6M trimmed.
- KBC Group's largest Q1 2017 buy was LogMein, Inc.: 156,863 shares worth $15.3M.
- KBC Group added most to Microsoft in Q1 2017, an estimated $45.7M increase.
- KBC Group's biggest Q1 2017 reduction was Pfizer, cutting an estimated $51.6M.
- KBC Group fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $16.2M.
- KBC Group's ten largest holdings make up 15% of its $11.1B portfolio in Q1 2017.
- KBC Group opened 66 new positions and closed 69 in Q1 2017.
- KBC Group's portfolio value rose 9.8% quarter-over-quarter to $11.1B.
Based on KBC Group's 13F filing for Q1 2017, filed 10 May 2017.